Effects of anti-glaucoma medications on gangion cell survival: the DBA/2J mouse model

We studied whether several agents, approved or undergoing trials in human glaucoma, were effective in preventing ganglion cell loss in the DBA/2J mouse. Adult DBA/2J mice were treated with timolol, pilocarpine, brimonidine, dorzolamide, or NMDA-receptor antagonist memantine. Surviving retinal ganglion cells of treated and control mice were retrogradely labeled with fluorogold and counted after whole mount preparation. In treated mice, only memantine and timolol had significant effects on retinal ganglion cell survival (P<0.0001, analysis of variance). Brimonidine was lethal to these mice, and these retinae were not analyzed further. The DBA/2J mouse represents a promising candidate for further experimentation in ocular hypertension.

[1]  Michael G. Anderson,et al.  Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice , 1999, Nature Genetics.

[2]  L A Wheeler,et al.  Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. , 1999, Investigative ophthalmology & visual science.

[3]  A. Acheampong,et al.  Preclinical Safety Profile of Brimonidine , 1996, European journal of ophthalmology.

[4]  B Becker,et al.  Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S M Podos,et al.  Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. , 1996, Archives of ophthalmology.

[6]  L. Enyedi,et al.  Safety and efficacy of brimonidine in children with glaucoma. , 2001, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[7]  Vision Research , 1961, Nature.

[8]  M. Bach,et al.  Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. , 1998, Investigative ophthalmology & visual science.

[9]  S. Sharma,et al.  Chronic ocular hypertension following episcleral venous occlusion in rats. , 1995, Experimental eye research.

[10]  H. Quigley,et al.  Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. , 2002, Investigative ophthalmology & visual science.

[11]  T H Roderick,et al.  Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. , 1998, Investigative ophthalmology & visual science.

[12]  A. Warbritton,et al.  Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. , 1995, Laboratory animal science.

[13]  R. Steiner,et al.  Ophthalmic drops causing coma in an infant. , 2001, The Journal of pediatrics.

[14]  S. John,et al.  Intraocular pressure in inbred mouse strains. , 1997, Investigative ophthalmology & visual science.

[15]  N. Osborne.  Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia , 1999, Visual Neuroscience.

[16]  Michael G. Anderson,et al.  Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice , 2001, BMC Genetics.

[17]  J. Morrison,et al.  Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma. , 1998, Investigative ophthalmology & visual science.

[18]  R. Taylor,et al.  Severe systemic toxicity caused by brimonidine drops in an infant with presumed juvenile xanthogranuloma , 1999, Eye.

[19]  N. Osborne,et al.  Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[20]  R. Greenberg.  Biometry , 1969, The Yale Journal of Biology and Medicine.

[21]  R. Strom,et al.  Genetic and Environmental Control of Variation in Retinal Ganglion Cell Number in Mice , 1996, The Journal of Neuroscience.

[22]  Janey L. Wiggs,et al.  Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice , 2002, Nature Genetics.

[23]  A. Cellerino,et al.  Free Radical Scavenging and Inhibition of Nitric Oxide Synthase Potentiates the Neurotrophic Effects of Brain-Derived Neurotrophic Factor on Axotomized Retinal Ganglion Cells In Vivo , 1998, The Journal of Neuroscience.

[24]  S. Lipton,et al.  Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. , 1996, Investigative ophthalmology & visual science.